Department of Defence Tender by Dg Armed Forces Medical Service (c37e096e)

ACEBROPHYLLIN 100MG and ACETYCSTINE 600MG TAB,ANTI PHLEBITIS CREAM TUBE OF 15 G or 20 G,ARIPIPRAZOL

Goods
Qty:4.2L

Tender Timeline

Tender Issue
May 27, 2025 at 11:23 AM

Tender Title: Medicine Demand ECHS RE 02

Reference Number: c37e096e

Issuing Authority:
Department of Defence
Ministry of Defence

Scope of Work and Objectives:
The primary objective of this tender is to procure a comprehensive range of medicines and medical supplies, specifically formulated to meet the needs of patients under the Ex-Servicemen Contributory Health Scheme (ECHS). This includes, but is not limited to, the provision of the following pharmaceutical items:

  • ACEBROPHYLLIN 100MG
  • ACETYCYSTEINE 600MG TAB
  • ANTI PHLEBITIS CREAM (TUBE OF 15 G or 20 G)
  • ARIPIPRAZOL 10 MG TAB
  • BUPROPION 150 MG TAB
  • CALCIUM ACETATE 667 MG TAB
  • And many others as detailed in the specifications.

The tender encompasses an estimated total quantity of 419,858 units across various medicine categories, reflecting a robust commitment to ensuring the availability of essential healthcare products for veterans and their families.

Eligibility Criteria:
Potential bidders must be legally registered entities with the appropriate licenses and authorizations for the distribution and supply of medical products. Compliance with all relevant government regulations pertaining to pharmaceuticals is mandatory.

Technical Requirements:
Bidders must provide proof of adherence to industry quality standards relevant to the pharmaceutical sector. Products must comply with specifications set by recognized health authorities, ensuring safety and efficacy for patient treatment.

Financial Requirements:
Bidders are required to submit a detailed financial proposal outlining pricing, payment terms, and any applicable taxes. Financial stability will be assessed to ensure the ability to deliver products without interruption.

Document Submission Details:
All required documentation must be submitted through the designated electronic procurement platform. This includes technical bid documents, financial quotes, and any supplementary certifications. Compliance with submission formats is crucial for acceptance.

Special Provisions:
This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups, recognizing their role in enhancing competition and innovation in the health sector.

Evaluation Process:
Bids will be evaluated based on technical compliance, financial robustness, and adherence to the tender specifications. The process will assess product quality, delivery capabilities, and overall value offered.

Delivery Locations:
All deliveries must be made to designated health facilities outlined in the tender documents. Specific logistics requirements will be communicated post-tender allocation.

Contact Information:
Further information can be obtained from the Department of Defence or through the electronic procurement platform designated for this tender.

Additional Information:

It is paramount that all participating vendors maintain strict adherence to compliance regulations and quality standards mandated by the Ministry of Defence. This ensures that the health requirements of ECHS beneficiaries are met efficiently and effectively. By engaging with this tender, vendors contribute to a vital initiative aimed at supporting the healthcare needs of veterans.


Tender BOQ Items

27 Items
1.

ACEBROPHYLLIN 100MG and ACETYCSTINE 600MG TAB

Qty:600
Unit:no
30
2.

ANTI PHLEBITIS CREAM TUBE OF 15 G or 20 G

Qty:60
Unit:no
30
3.

ARIPIPRAZOLE 10 MG TAB

Qty:1800
Unit:no
30
4.

BUPROPION 150 MG TAB

Qty:6360
Unit:no
30
5.

CALCIUM ACETATE 667 MG TAB

Qty:3400
Unit:no
30
6.

CILOSTAZOL 100 MG TAB

Qty:3000
Unit:no
30
7.

CIPROFLOXACIN 500MG TAB

Qty:8400
Unit:no
30
8.

DICLOFENAC and PARACETAMOL and SERRATIOPEPTIDASE TAB

Qty:320000
Unit:no
30
9.

DICLOFENAC GEL 1 Percentage

Qty:24200
Unit:tube
30
10.

ED CIPROFLOXACIN 0 point 3 Percentage

Qty:840
Unit:bott
30
11.

ED MOXIFLOXACIN and DEXAMETHASONE

Qty:480
Unit:no
30
12.

FLUPENTIXOL 0 point 5 MG and MELITRACEN 10 MG TAB

Qty:2300
Unit:no
30
13.

FOLEYS CATHETER 2 WAY SIZE 16 FR

Qty:340
Unit:no
30
14.

INJ DEXAMETHASONE 2 ML VIAL

Qty:45
Unit:vial
30
15.

INJ DILTIAZEM

Qty:3
Unit:vial
30
16.

INSULIN SYRINGE DISPOSABLE

Qty:18200
Unit:no
30
17.

KETOCONAZOLE LOTION 2 Percentage and ZINC PYRITHIONE BOTTLE OF 60ML

Qty:1380
Unit:bott
30
18.

MESALAMINE SUPPOSITORY

Qty:1080
Unit:no
30
19.

METFORMIN HCL 500 MG and MYOINOSITOL 600 MG TAB

Qty:600
Unit:no
30
20.

NORFLOXACIN 400MG TAB

Qty:1200
Unit:no
30
21.

OESTROGEN CONJUGATED NATURAL OESTROGEN 0 pont 625 MG TAB

Qty:400
Unit:no
30
22.

POVIDONE IODINE IP 5 Percentage W per W TUBE OF 15 GM

Qty:870
Unit:tube
30
23.

PRASUGREL 10 MG TAB

Qty:660
Unit:no
30
24.

SERTRALINE 50 MG TAB

Qty:15600
Unit:no
30
25.

SILODOSIN 4 MG TAB

Qty:1800
Unit:no
30
26.

TENOFOVIR ALAFENAMIDE 25 MG TAB

Qty:840
Unit:no
30
27.

THIAMINE 100MG TAB

Qty:5400
Unit:no
30

General Information

Item Category
ACEBROPHYLLIN 100MG and ACETYCSTINE 600MG TAB , ANTI PHLEBITIS CREAM TUBE OF 15 G or 20 G , ARIPIPRAZOLE 10 MG TAB , BUPROPION 150 MG TAB , CALCIUM ACETATE 667 MG TAB , CILOSTAZOL 100 MG TAB , CIPROFLOXACIN 500MG TAB , DICLOFENAC and PARACETAMOL and SERRATIOPEPTIDASE TAB , DICLOFENAC GEL 1 Percentage , ED CIPROFLOXACIN 0 point 3 Percentage , ED MOXIFLOXACIN and DEXAMETHASONE , FLUPENTIXOL 0 point 5 MG and MELITRACEN 10 MG TAB , FOLEYS CATHETER 2 WAY SIZE 16 FR , INJ DEXAMETHASONE 2 ML VIAL , INJ DILTIAZEM , INSULIN SYRINGE DISPOSABLE , KETOCONAZOLE LOTION 2 Percentage and ZINC PYRITHIONE BOTTLE OF 60ML , MESALAMINE SUPPOSITORY , METFORMIN HCL 500 MG and MYOINOSITOL 600 MG TAB , NORFLOXACIN 400MG TAB , OESTROGEN CONJUGATED NATURAL OESTROGEN 0 pont 625 MG TAB , POVIDONE IODINE IP 5 Percentage W per W TUBE OF 15 GM , PRASUGREL 10 MG TAB , SERTRALINE 50 MG TAB , SILODOSIN 4 MG TAB , TENOFOVIR ALAFENAMIDE 25 MG TAB , THIAMINE 100MG TAB
Ministry Name
Department Name

Financial Information

OEM Average Turnover
₹50.00 Lakh (s)
Minimum Turnover
₹10.00 Lakh (s)
Bid Offer Validity
90 (Days)
Past Performance
60 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7886383.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC)
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Frequently Asked Questions

The eligibility requirements include being a registered entity with appropriate licenses and certifications for the distribution of medical products. Bidders must comply with all local and national regulations regarding pharmaceutical supply chains. Additionally, past performance records and financial stability assessments may be considered to ensure that suppliers can meet the commitments required.

The technical specifications dictate that all products must conform to established quality standards as outlined by relevant health authorities. Items must be obtained from accredited manufacturers and suppliers, ensuring that they are safe and effective for patients’ use. Certifications demonstrating compliance with quality measures, such as Good Manufacturing Practices (GMP), are essential.

The Earnest Money Deposit (EMD) is a financial guarantee required from bidders to participate in the tender. The specifics regarding the amount and method of payment will be detailed in the tender documents. The EMD is typically refundable upon conclusion of the tendering process, barring any contractual breaches.

Document submissions must be conducted through the specified electronic procurement platform. Vendors should ensure that all documents are uploaded in the required formats, such as PDF or not exceeding the permissible size limit. Incomplete submissions or incorrect formats may lead to disqualification.

Participating as a Micro, Small, or Medium Enterprise (MSE) in this tender provides several advantages. MSEs may benefit from reduced eligibility criteria, relaxed financial requirements, and preferential evaluation during the selection process. This initiative not only fosters inclusion but also stimulates competitive pricing and innovation within the healthcare supply sector.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders